Michael S. Rafii

Affiliations: 
2008-2016 Neuroscience University of California, San Diego, La Jolla, CA 
 2016- Neurology University of Southern California Keck School of Medicine 
Area:
Neurodegenerative Diseases
Google:
"Michael Rafii"
Mean distance: 15.77 (cluster 11)
 
SNBCP

Parents

Sign in to add mentor
Carl W. Cotman research assistant UC Irvine
Justin R. Fallon grad student 1997-2002 Brown
 (Roles for the proteoglycan biglycan in muscular dystrophy and neuromuscular junction formation.)
Leon J. Thal post-doc 2006-2008 UCSD
Paul S. Aisen research scientist 2007-2007
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Russell JK, Conley AC, Boyd BD, et al. (2025) Brain cholinergic terminal density utilizing [F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 21: e70134
Jimenez-Maggiora GA, Donohue MC, Rafii MS, et al. (2025) Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials. The Journal of Prevention of Alzheimer's Disease. 12: 100002
Sukreet S, Goodwill V, Ngolab J, et al. (2025) Basic Science and Pathogenesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. e092874
Leal CBQS, Zimmer CGM, Sinatti VVC, et al. (2024) Effects of the therapeutic correction of U1 snRNP complex on Alzheimer's disease. Scientific Reports. 14: 30085
Rafii MS. (2024) The amyloid clock: mapping Alzheimer's disease in Down syndrome. The Lancet. Neurology. 23: 1173-1174
Boerwinkle AH, Wisch JK, Handen BL, et al. (2024) The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sukreet S, Goodwill VS, Ngolab J, et al. (2024) Clinical and neuropathological analysis of Down syndrome over 7 decades of life. Journal of Neuropathology and Experimental Neurology
Aisen PS, Donohue MC, Raman R, et al. (2024) The Alzheimer's Disease Neuroimaging Initiative Clinical Core. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Jack CR, Andrews SJ, Beach TG, et al. (2024) Revised criteria for the diagnosis and staging of Alzheimer's disease. Nature Medicine
Krasny S, Yan C, Hartley SL, et al. (2024) Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
See more...